Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with breast cancer, confirmed through lab and tissue testing
- People who are currently receiving chemotherapy before surgery (known as neoadjuvant chemotherapy)
- People aged between 18 and 65 years old
- People rated as ASA Grade I to III, which is a medical assessment of overall physical health before a procedure (confirm with trial site)
- People with a body mass index (BMI) between 18 and 30 kg/m²
Who may not be able to join:
- People who do not wish to take part in the study
- People with a BMI higher than 30 kg/m²
- People with a recent history of drug abuse
- People who are allergic to esketamine or for whom esketamine is medically unsuitable
- People who have difficulty with memory, thinking, or communication
- People with serious problems affecting major organs such as the liver or kidneys
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: xiaoliang wang, The First Affiliated Hospital with Nanjing Medical University
Phone: +8615366110306
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The incidence of PSD on postoperative day -1
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.